ZOETIS INC (1ZTS.MI) Fundamental Analysis & Valuation

BIT:1ZTS • US98978V1035

Current stock price

99.23 EUR
-10.43 (-9.51%)
Last:

This 1ZTS.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. 1ZTS.MI Profitability Analysis

1.1 Basic Checks

  • 1ZTS had positive earnings in the past year.
  • 1ZTS had a positive operating cash flow in the past year.
  • In the past 5 years 1ZTS has always been profitable.
  • 1ZTS had a positive operating cash flow in each of the past 5 years.
1ZTS.MI Yearly Net Income VS EBIT VS OCF VS FCF1ZTS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • 1ZTS has a better Return On Assets (17.28%) than 92.31% of its industry peers.
  • 1ZTS has a Return On Equity of 80.25%. This is amongst the best in the industry. 1ZTS outperforms 98.08% of its industry peers.
  • The Return On Invested Capital of 1ZTS (21.95%) is better than 88.46% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1ZTS is significantly above the industry average of 13.99%.
Industry RankSector Rank
ROA 17.28%
ROE 80.25%
ROIC 21.95%
ROA(3y)17.05%
ROA(5y)15.99%
ROE(3y)59.76%
ROE(5y)54.42%
ROIC(3y)22.23%
ROIC(5y)21.04%
1ZTS.MI Yearly ROA, ROE, ROIC1ZTS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

1.3 Margins

  • 1ZTS's Profit Margin of 28.23% is amongst the best of the industry. 1ZTS outperforms 88.46% of its industry peers.
  • 1ZTS's Profit Margin has improved in the last couple of years.
  • The Operating Margin of 1ZTS (38.54%) is better than 92.31% of its industry peers.
  • 1ZTS's Operating Margin has improved in the last couple of years.
  • 1ZTS has a Gross Margin (71.89%) which is comparable to the rest of the industry.
  • 1ZTS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 38.54%
PM (TTM) 28.23%
GM 71.89%
OM growth 3Y1.57%
OM growth 5Y2.33%
PM growth 3Y2.57%
PM growth 5Y2.85%
GM growth 3Y1.04%
GM growth 5Y0.73%
1ZTS.MI Yearly Profit, Operating, Gross Margins1ZTS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. 1ZTS.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 1ZTS is creating value.
  • 1ZTS has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, 1ZTS has less shares outstanding
  • 1ZTS has a worse debt/assets ratio than last year.
1ZTS.MI Yearly Shares Outstanding1ZTS.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
1ZTS.MI Yearly Total Debt VS Total Assets1ZTS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • An Altman-Z score of 5.37 indicates that 1ZTS is not in any danger for bankruptcy at the moment.
  • 1ZTS has a better Altman-Z score (5.37) than 78.85% of its industry peers.
  • 1ZTS has a debt to FCF ratio of 3.96. This is a good value and a sign of high solvency as 1ZTS would need 3.96 years to pay back of all of its debts.
  • 1ZTS's Debt to FCF ratio of 3.96 is in line compared to the rest of the industry. 1ZTS outperforms 57.69% of its industry peers.
  • 1ZTS has a Debt/Equity ratio of 2.71. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 2.71, 1ZTS is not doing good in the industry: 80.77% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.71
Debt/FCF 3.96
Altman-Z 5.37
ROIC/WACC2.45
WACC8.97%
1ZTS.MI Yearly LT Debt VS Equity VS FCF1ZTS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 3.03 indicates that 1ZTS has no problem at all paying its short term obligations.
  • 1ZTS's Current ratio of 3.03 is amongst the best of the industry. 1ZTS outperforms 90.38% of its industry peers.
  • A Quick Ratio of 1.94 indicates that 1ZTS should not have too much problems paying its short term obligations.
  • 1ZTS's Quick ratio of 1.94 is amongst the best of the industry. 1ZTS outperforms 88.46% of its industry peers.
Industry RankSector Rank
Current Ratio 3.03
Quick Ratio 1.94
1ZTS.MI Yearly Current Assets VS Current Liabilites1ZTS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. 1ZTS.MI Growth Analysis

3.1 Past

  • 1ZTS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.45%, which is quite good.
  • 1ZTS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.77% yearly.
  • Looking at the last year, 1ZTS shows a small growth in Revenue. The Revenue has grown by 2.28% in the last year.
  • 1ZTS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.24% yearly.
EPS 1Y (TTM)8.45%
EPS 3Y9.57%
EPS 5Y10.77%
EPS Q2Q%5.71%
Revenue 1Y (TTM)2.28%
Revenue growth 3Y5.42%
Revenue growth 5Y7.24%
Sales Q2Q%3.02%

3.2 Future

  • The Earnings Per Share is expected to grow by 7.80% on average over the next years.
  • 1ZTS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.30% yearly.
EPS Next Y10.25%
EPS Next 2Y8.92%
EPS Next 3Y8.7%
EPS Next 5Y7.8%
Revenue Next Year4.91%
Revenue Next 2Y4.88%
Revenue Next 3Y4.85%
Revenue Next 5Y5.3%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1ZTS.MI Yearly Revenue VS Estimates1ZTS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
1ZTS.MI Yearly EPS VS Estimates1ZTS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. 1ZTS.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 17.82 indicates a rather expensive valuation of 1ZTS.
  • 1ZTS's Price/Earnings ratio is in line with the industry average.
  • 1ZTS is valuated rather cheaply when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 16.16, the valuation of 1ZTS can be described as correct.
  • Based on the Price/Forward Earnings ratio, 1ZTS is valued a bit cheaper than the industry average as 67.31% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 38.20. 1ZTS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 17.82
Fwd PE 16.16
1ZTS.MI Price Earnings VS Forward Price Earnings1ZTS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1ZTS indicates a somewhat cheap valuation: 1ZTS is cheaper than 63.46% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, 1ZTS is valued a bit cheaper than the industry average as 61.54% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 21.15
EV/EBITDA 13.3
1ZTS.MI Per share data1ZTS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of 1ZTS may justify a higher PE ratio.
PEG (NY)1.74
PEG (5Y)1.65
EPS Next 2Y8.92%
EPS Next 3Y8.7%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. 1ZTS.MI Dividend Analysis

5.1 Amount

  • 1ZTS has a Yearly Dividend Yield of 1.64%. Purely for dividend investing, there may be better candidates out there.
  • 1ZTS's Dividend Yield is comparable with the industry average which is at 1.95.
  • 1ZTS's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.64%

5.2 History

  • The dividend of 1ZTS is nicely growing with an annual growth rate of 20.56%!
Dividend Growth(5Y)20.56%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 1ZTS pays out 33.26% of its income as dividend. This is a sustainable payout ratio.
  • 1ZTS's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP33.26%
EPS Next 2Y8.92%
EPS Next 3Y8.7%
1ZTS.MI Yearly Income VS Free CF VS Dividend1ZTS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
1ZTS.MI Dividend Payout.1ZTS.MI Dividend Payout, showing the Payout Ratio.1ZTS.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

1ZTS.MI Fundamentals: All Metrics, Ratios and Statistics

ZOETIS INC

BIT:1ZTS (3/23/2026, 7:00:00 PM)

99.23

-10.43 (-9.51%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-12
Earnings (Next)04-30
Inst Owners100.79%
Inst Owner ChangeN/A
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap41.89B
Revenue(TTM)9.47B
Net Income(TTM)2.67B
Analysts76.8
Price Target132.47 (33.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.64%
Yearly Dividend1.77
Dividend Growth(5Y)20.56%
DP33.26%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.16%
Min EPS beat(2)3.79%
Max EPS beat(2)4.53%
EPS beat(4)4
Avg EPS beat(4)5.31%
Min EPS beat(4)3.79%
Max EPS beat(4)7.75%
EPS beat(8)8
Avg EPS beat(8)4.82%
EPS beat(12)10
Avg EPS beat(12)3.31%
EPS beat(16)12
Avg EPS beat(16)3.06%
Revenue beat(2)1
Avg Revenue beat(2)-0.66%
Min Revenue beat(2)-1.44%
Max Revenue beat(2)0.13%
Revenue beat(4)3
Avg Revenue beat(4)0.04%
Min Revenue beat(4)-1.44%
Max Revenue beat(4)1.11%
Revenue beat(8)6
Avg Revenue beat(8)0.76%
Revenue beat(12)6
Avg Revenue beat(12)0.17%
Revenue beat(16)7
Avg Revenue beat(16)-0.2%
PT rev (1m)-0.76%
PT rev (3m)-5.91%
EPS NQ rev (1m)2.57%
EPS NQ rev (3m)2.86%
EPS NY rev (1m)3.06%
EPS NY rev (3m)3.57%
Revenue NQ rev (1m)-0.26%
Revenue NQ rev (3m)-0.34%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.07%
Valuation
Industry RankSector Rank
PE 17.82
Fwd PE 16.16
P/S 5.1
P/FCF 21.15
P/OCF 16.62
P/B 14.49
P/tB N/A
EV/EBITDA 13.3
EPS(TTM)5.57
EY5.61%
EPS(NY)6.14
Fwd EY6.19%
FCF(TTM)4.69
FCFY4.73%
OCF(TTM)5.97
OCFY6.02%
SpS19.46
BVpS6.85
TBVpS-0.89
PEG (NY)1.74
PEG (5Y)1.65
Graham Number29.2929 (-70.48%)
Profitability
Industry RankSector Rank
ROA 17.28%
ROE 80.25%
ROCE 27.58%
ROIC 21.95%
ROICexc 26.6%
ROICexgc 40.59%
OM 38.54%
PM (TTM) 28.23%
GM 71.89%
FCFM 24.12%
ROA(3y)17.05%
ROA(5y)15.99%
ROE(3y)59.76%
ROE(5y)54.42%
ROIC(3y)22.23%
ROIC(5y)21.04%
ROICexc(3y)26.94%
ROICexc(5y)27.11%
ROICexgc(3y)44.63%
ROICexgc(5y)48.4%
ROCE(3y)27.92%
ROCE(5y)26.43%
ROICexgc growth 3Y-11.38%
ROICexgc growth 5Y-5.24%
ROICexc growth 3Y-2.74%
ROICexc growth 5Y2.7%
OM growth 3Y1.57%
OM growth 5Y2.33%
PM growth 3Y2.57%
PM growth 5Y2.85%
GM growth 3Y1.04%
GM growth 5Y0.73%
F-Score6
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 2.71
Debt/FCF 3.96
Debt/EBITDA 2.19
Cap/Depr 127.52%
Cap/Sales 6.56%
Interest Coverage 13.98
Cash Conversion 70.21%
Profit Quality 85.41%
Current Ratio 3.03
Quick Ratio 1.94
Altman-Z 5.37
F-Score6
WACC8.97%
ROIC/WACC2.45
Cap/Depr(3y)136.13%
Cap/Depr(5y)128.18%
Cap/Sales(3y)7.4%
Cap/Sales(5y)7.12%
Profit Quality(3y)82.33%
Profit Quality(5y)78.99%
High Growth Momentum
Growth
EPS 1Y (TTM)8.45%
EPS 3Y9.57%
EPS 5Y10.77%
EPS Q2Q%5.71%
EPS Next Y10.25%
EPS Next 2Y8.92%
EPS Next 3Y8.7%
EPS Next 5Y7.8%
Revenue 1Y (TTM)2.28%
Revenue growth 3Y5.42%
Revenue growth 5Y7.24%
Sales Q2Q%3.02%
Revenue Next Year4.91%
Revenue Next 2Y4.88%
Revenue Next 3Y4.85%
Revenue Next 5Y5.3%
EBIT growth 1Y7.54%
EBIT growth 3Y7.08%
EBIT growth 5Y9.74%
EBIT Next Year18.93%
EBIT Next 3Y9.75%
EBIT Next 5Y8.5%
FCF growth 1Y-0.65%
FCF growth 3Y19.85%
FCF growth 5Y6.41%
OCF growth 1Y-1.66%
OCF growth 3Y14.95%
OCF growth 5Y6.44%

ZOETIS INC / 1ZTS.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ZOETIS INC (1ZTS.MI) stock?

ChartMill assigns a fundamental rating of 6 / 10 to 1ZTS.MI.


Can you provide the valuation status for ZOETIS INC?

ChartMill assigns a valuation rating of 4 / 10 to ZOETIS INC (1ZTS.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for ZOETIS INC?

ZOETIS INC (1ZTS.MI) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for 1ZTS stock?

The Price/Earnings (PE) ratio for ZOETIS INC (1ZTS.MI) is 17.82 and the Price/Book (PB) ratio is 14.49.


What is the earnings growth outlook for ZOETIS INC?

The Earnings per Share (EPS) of ZOETIS INC (1ZTS.MI) is expected to grow by 10.25% in the next year.